Last week’s news that J&J is abandoning their coronary stent business was sad, but provided several lessons about poor product development execution and the need for constant innovation. J&J created ...

India's cardiac stent market was certainly the last thing on Commerce Minister Nirmala Sitharaman's mind when she said that the restrictive visa regime being planned by the US can have an (adverse) ...

While Abbott has threatened to withdraw its `high-end' Xience Alpine stent saying the new price cap on stents makes it commercially unviable, the company's filing with the US Food and Drug ...